Saturday 17 October 2026 Export SGMT’s income statement to Excel — free account

Sagimet Biosciences Inc.

Sagimet Biosciences Inc.’s revenue for fiscal 2023 (year ended December 2023) was $2.0 million. In the quarter to June 2026, EPS grew 18.8% and free cash flow fell 22.0%, each against the same quarter a year earlier.

8.02 0.15 −1.84%

Follow SGMT

Alert me

Market cap: $574.7M
P/E: 0.0×
Fwd P/E: −2.3×
Dividend yield: —
F-score: n/a
Altman Z: 2.50
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(24.37%)	(36.04%)	(38.20%)	(39.78%)	+8 more TTM periods Free account
ROA Full definition →	(23.49%)	(34.27%)	(36.89%)	(38.04%)
ROIC Full definition →	(205.24%)	0.00%	0.00%	(1,569.06%)
Return on Tangible Assets Full definition →	(19.73%)	(42.48%)	(45.86%)	(52.27%)
Free Cash Flow per Share Full definition →	(0.79)	(1.22)	(1.41)	(1.38)
Free Cash Flow Full definition →	(41.72)	(39.72)	(45.65)	(44.84)
Other line items
Cash ROIC Full definition →	(8.41%)	(19.19%)	(20.33%)	(19.00%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.89	0.91	0.89	0.78
Depreciation/Fixed assets Full definition →	0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.79)	(1.22)	(1.41)	(1.38)
Capex per Share Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly